| Literature DB >> 16490769 |
Ilya Okun1, Sergei Malarchuk, Elena Dubrovskaya, Alexander Khvat, Sergey Tkachenko, Volodymyr Kysil, Alexey Ilyin, Dmitry Kravchenko, Eric R Prossnitz, Larry Sklar, Alexandre Ivachtchenko.
Abstract
From the authors' 650,000 compound collection, they have selected approximately 15,000 potential small-molecule protease inhibitors, which were subjected to high-throughput screening against caspase-3. The screening yielded a series of hits that belong to 11 different scaffolds. Based on the structure of one of the hits, a new class of the small-molecule inhibitors with a double electrophilic warhead, 8-sulfonyl-pyrrolo[3,4-c]quinoline-1,3-diones (SPQ), was synthesized and tested in follow-up mechanistic and anti-apoptosis assays. Mechanistic analysis of a representative compound of this class, CD-001-0011, showed that the compound exhibited a high potency (IC (50)=130 nM), was reversible though noncompetitive, and had a broad selectivity profile to other caspases belonging to groups I to III. The compound was effective in preventing staurosporine induced apoptosis in a few cell lines and retinoic acid-induced apoptosis in zebrafish.Entities:
Mesh:
Substances:
Year: 2006 PMID: 16490769 DOI: 10.1177/1087057105285048
Source DB: PubMed Journal: J Biomol Screen ISSN: 1087-0571